Medigene AG
Medigene AG (MDGEF) Revenue
Annual & quarterly revenue history · segment & region breakdown
MDGEF · revenue · updated Jun 15, 2026
Core revenue metrics
Trailing 12 monthsMedigene AG trailing twelve-month (TTM) revenue is $0.02B, a decrease of 80.69% year-over-year from $0.01B in FY2023.
Revenue trend
2023 – 2004 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2023-12-31 | $0.01B | -$0.03B | -80.69% |
| 2022-12-31 | $0.03B | +$0.02B | +198.64% |
| 2021-12-31 | $0.01B | +$0.00B | +30.75% |
| 2020-12-31 | $0.01B | -$0.00B | -23.87% |
| 2019-12-31 | $0.01B | +$0.00B | +38.74% |
| 2018-12-31 | $0.01B | -$0.00B | -1.30% |
| 2017-12-31 | $0.01B | +$0.00B | +87.17% |
| 2016-12-31 | $0.00B | +$0.00B | +32.25% |
| 2015-12-31 | $0.00B | -$0.01B | -75.35% |
| 2014-12-31 | $0.01B | +$0.01B | +66.68% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Medigene AG receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Medigene AG reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in EUR.
Data sourced from Medigene AG's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MDGEF revenue · 4 questionsMDGEF's trailing twelve-month (TTM) revenue is $0.02B. That is a decrease of 80.69% year-over-year from $0.01B in FY2023.
▸ Source: FMP · Medigene AG SEC filings · GAAP · Medigene AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026